Maastricht · LI, Netherlands · founded 2017 · https://www.psylaris.com/
Diligence memoA one-page analyst read on Psylaris — recommendation, valuation, rhythm, risks.→Psylaris: limited disclosed financing to assess.
Synthesized from the figures below est. — every claim rests on a number shown on this page.
AI analyst read est. — model-extracted from this company's public description, not a verified fact. 30%
operates a technology-led product inferred from public copy
Grounded in: “You are a venture analyst”
Psychotherapy through autonomous and personalized VR-sessions.
We empower mental healthcare clients with virtual reality sessions that are additive to traditional therapy. Clients regain their self-reliance the moment they are given the chance to contribute to their treatment. Therapists can focus on the aspects of treatment that e-health is not equiped to deal with. Treatment efficiency goes up - costs go down: E-health the way it was meant to be.
As reported in public records reported — not modeled.
Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.
No round amounts on record to chart.
No staged rounds to sequence.
Round size and date are reported; the stage label is inferred from round size. Valuation is modeled from stage benchmarks. Directional, not a quoted figure.
Not enough modeled valuation points to chart a trajectory.
Benchmarked against 8525 companies in this sector. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.
Raised more than 96% of sector peers (real $). Modeled value above 96% of peers (estimate).
Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.
| Stage | Amount · real | Announced | Post-money · est | Value · est | Conf. |
|---|---|---|---|---|---|
| No rounds recorded. | |||||
Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.
Psylaris is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.
Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.
| Company | Sector | Stage | Value · est | Match |
|---|---|---|---|---|
| Virtual Therapy, Inc. | Other | Pre-Seed | $1.4M | 77% |
| Pacific Psychotherapy Technologies, Inc. | Software / Tech | Series B | $683.7M | 76% |
| HealthSpark Empowering Physical Therapists to Go Independent | Healthtech | — | — | 75% |
| Mindstate Design Labs, Inc. Clinical-stage AI neuroengineering platform | Biotech | Series A | $56.1M | 75% |
| Synapticure, Inc. We deliver personalized medicine for neurodegenerative patients | Biotech | Series C | $332.6M | 74% |
| Mind Emulation Foundation | — | — | — | 74% |
| Virtual Health Partners, Inc. | Healthtech | Seed | $43.1M | 74% |
| VR Health Network Inc. | Healthtech | Pre-Seed | $11.7M | 74% |
See where Psylaris sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.
If you work at Psylaris, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.
Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.